China Medical System Holdings Ltd.

As of June 30, 2026, China Medical System Holdings Ltd. carries a market capitalization of 25.01B, placing it among publicly traded companies globally. Its enterprise value stands at 19.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

China Medical System Holdings Ltd.'s next confirmed earnings release is scheduled for March 16, 2027.

As of June 30, 2026, China Medical System Holdings Ltd. has 2.43B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, China Medical System Holdings Ltd. maintains a current ratio of 6.64, meaning it holds 6.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, China Medical System Holdings Ltd.'s stock has declined approximately 25.07% over the past 52 weeks. The 50-day moving average sits at 10.97, while the 200-day moving average is 12.33.

As of June 30, 2026, China Medical System Holdings Ltd. holds 6.65B in cash and equivalents against 1.02B in total debt, resulting in a net debt position of -2.01B. Total book value stands at 20.74B, with working capital of 9.09B providing operational flexibility.

China Medical System Holdings Ltd.'s most recent stock split took place on April 27, 2012 with a 2:3 split ratio.